PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
15-Feb-2024 REAL-WORLD EVIDENCE DEMONSTRATES FEASIBILITY AND SAFETY OF OUTPATIENT ADMINISTRATION OF YESCARTA® (AXICABTAGENE CILOLEUCEL) Kite, a Gilead Company
14-Feb-2024 ESMT Berlin and BCG publish index comparing biotech innovation hubs in Europe DEEP Institute at ESMT Berlin
13-Feb-2024 New six-figure fund to support talented individuals work across industry, academia and the NHS The Academy of Medical Sciences
13-Feb-2024 Anocca Appoints Martin Welschof to Board of Directors Anocca AB
13-Feb-2024 DelSiTech and Tolmar Announce Global License and Development Agreement DelSiTech
13-Feb-2024 Sosei Heptares Operational Highlights and Consolidated Results for 12 Months ended 31 December 2023 Sosei Group Corporation
13-Feb-2024 New Veeva Vault Submissions Publishing eLearning Application Speeds Employee Onboarding Veeva Systems
13-Feb-2024 StromaCare appoints Georges Rawadi as CEO Andrew Lloyd Associates
12-Feb-2024 Independent Research Confirms >$10bn Market Opportunity for POLB 001 as a Preventative Therapy for Cancer Immunotherapy-Induced Cytokine Release Syndrome (CRS) Poolbeg Pharma
12-Feb-2024 Biotech start-up BugBiome secures investment for pioneering research in sustainable pest protection BugBiome
09-Feb-2024 Invitation to Semantic Data 2024: Taxonomy, Ontology and, Knowledge Graphs Henry Stewart Events
09-Feb-2024 ELRIG UK Announces Steve Bates and Dr Anderson Ryan as Keynote Speakers at Research and Innovation 2024 ELRIG UK
09-Feb-2024 LogiPharma Unveils Dedicated Conference Tracks for 2024 LogiPharma
08-Feb-2024 Abzena Launches LabZientâ„¢, an Analytical Platform to Expedite the Path to IND for Antibodies Abzena
08-Feb-2024 Alfa Chemistry Releases Carbomer Series Products for Cosmetics and Personal Care Products Manufacturing Alfa Chemistry
07-Feb-2024 Invizius Treats First Patients in First-In-Human Phase 1 Clinical Study of Lead Dialysis Product H-Guard® Invizius
07-Feb-2024 Magnitude Biosciences announces significant growth trajectory as CEO is recognised as game-changing industry leader Magnitude Biosciences
07-Feb-2024 CD Formulation Shows the Ability of Coated Microneedle Preparation Technology for Novel Drug Delivery CD Formulation
07-Feb-2024 CdS/ZnS Quantum Dots Are Now Available at Alfa Chemistry Alfa Chemistry
06-Feb-2024 Operations Update Roquefort Therapeutics plc